trending Market Intelligence /marketintelligence/en/news-insights/trending/gghxd0chgeuiejieuktjja2 content esgSubNav
In This List

Moody's places Express Scripts' ratings under review for downgrade

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Moody's places Express Scripts' ratings under review for downgrade

Moody's placed Express Scripts Holding Co.'s Baa2 senior unsecured debt under review for downgrade.

The rating agency placed the ratings under review with direction uncertain in March, after Cigna Corp. agreed to acquire Express Scripts for about $67 billion.

Moody's said the rating of the St. Louis, Mo.-based pharmacy benefit manager is unlikely to be upgraded, based on the progress to date in the rating review of Bloomfield, Conn.-based Cigna.

Express Scripts's Baa2 rating reflects its leading position in the market, moderate financial leverage and strong cash flow, according to Moody's.